文献速递其他结缔组织病

两个独立系统性硬化症队列中血中性粒细胞计数及中性粒细胞与淋巴细胞比值对疾病进展和死亡率的预测

Blood Neutrophil Count and Neutrophil-to-Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis Cohorts.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2022-11-17

在GENISOS和SLS II两个系统性硬化症队列中前瞻性测量中性粒细胞与淋巴细胞计数,评估其预测疾病严重程度和死亡率的价值。GENISOS队列447例中377例(84.3%)有基线血细胞计数,基线中性粒细胞计数和NLR较高可预测随访中FVC%较低和MRSS较高,并预测长期死亡风险增加(HR 1.42,P=0.02和HR 1.48,P<0.001)。SLS II队列证实了上述预测意义。

要点

  • 基线中性粒细胞计数和NLR较高可预测随访中FVC%较低(b=-4.74,P=0.009和b=-2.68,P=0.028)。
  • 基线中性粒细胞计数和NLR较高可预测随访中MRSS较高(b=4.07,P<0.001和b=2.32,P<0.001)。
  • 调整基线人口学和临床因素后,基线中性粒细胞计数和NLR仍预测长期死亡风险增加(HR 1.42,P=0.02和HR 1.48,P<0.001)。

核心结论

  • 较高的血中性粒细胞计数和NLR可预测更严重的疾病病程和死亡率增加,提示这些易于获取的实验室检查可能反映了SSc的病理免疫过程。

研究设计与样本

  • 在GENISOS和SLS II两个独立队列中前瞻性测量中性粒细胞和淋巴细胞计数,采用广义线性混合模型进行纵向分析,采用Cox比例风险模型评估对死亡率的预测意义。
  • GENISOS队列分析时共447例SSc患者,其中377例(84.3%)有基线血中性粒细胞和淋巴细胞计数可用。

主要发现

  • 在GENISOS队列中,基线中性粒细胞计数和NLR较高可预测随访中FVC%较低(b=-4.74,P=0.009和b=-2.68,P=0.028)。
  • 在GENISOS队列中,基线中性粒细胞计数和NLR较高可预测随访中MRSS较高(b=4.07,P<0.001和b=2.32,P<0.001)。
  • 纵向中性粒细胞和NLR测量值与同期FVC%较低及同期MRSS较高显著相关。
  • 在GENISOS队列中,调整基线人口学和临床因素后,基线中性粒细胞计数和NLR仍预测长期死亡风险增加(HR 1.42,P=0.02和HR 1.48,P<0.001)。
  • 在SLS II队列中证实了基线中性粒细胞计数和NLR较高对FVC%下降和长期死亡率增加的预测意义。

关键数值与推荐

  • 基线中性粒细胞计数较高预测随访FVC%较低:b=-4.74,P=0.009。
  • 基线NLR较高预测随访FVC%较低:b=-2.68,P=0.028。
  • 基线中性粒细胞计数较高预测随访MRSS较高:b=4.07,P<0.001。
  • 基线NLR较高预测随访MRSS较高:b=2.32,P<0.001。
  • 基线中性粒细胞计数较高预测长期死亡风险增加:HR 1.42,P=0.02;基线NLR较高预测长期死亡风险增加:HR 1.48,P<0.001。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the predictive significance of blood neutrophil count and the ratio between neutrophil and lymphocyte count (neutrophil-to-lymphocyte ratio [NLR]) for disease severity and mortality in systemic sclerosis (SSc). METHODS: Neutrophil and lymphocyte counts were prospectively measured in the Genetics versus Environment in Scleroderma Outcome Study (GENISOS) and the Scleroderma Lung Study II (SLS II). Forced vital capacity percent predicted (FVC%) and modified Rodnan skin thickness score (MRSS) were used as surrogate measures for disease severity. Longitudinal analyses were performed using generalized linear mixed models. Cox proportional hazards models evaluated the predictive significance of these cell counts for mortality. RESULTS: Of the 447 SSc patients in the GENISOS cohort at the time of analysis, 377 (84.3%) had available baseline blood neutrophil and lymphocyte counts. Higher baseline neutrophil count and NLR predicted lower serially obtained FVC% (b = -4.74, P = 0.009 and b = -2.68, P = 0.028, respectively) and higher serially obtained MRSS (b = 4.07, P < 0.001 and b = 2.32, P < 0.001, respectively). Longitudinal neutrophil and NLR measurements also significantly correlated with lower concurrently obtained FVC% measurements and higher concurrently obtained MRSS. Baseline neutrophil count and NLR predicted increased risk of long-term mortality, even after adjustment for baseline demographic and clinical factors (hazard ratio [HR] 1.42, P = 0.02 and HR 1.48, P < 0.001, respectively). The predictive significance of higher baseline neutrophil count and NLR for declining FVC% and increased long-term mortality was confirmed in the SLS II. CONCLUSION: Higher blood neutrophil count and NLR are predictive of more severe disease course and increased mortality, indicating that these easily obtainable laboratory studies might be a reflection of pathologic immune processes in SSc.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Wareing N, Mohan V, Taherian R, et al. Blood Neutrophil Count and Neutrophil-to-Lymphocyte Ratio for Prediction of Disease Progression and Mortality in Two Independent Systemic Sclerosis Cohorts. Arthritis Care Res (Hoboken). 2022. PMID: 35287250. doi:10.1002/acr.24880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。